Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI)
$0.40
-0.0200 ( -4.80% ) 76.0K
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
Market Data
Open
$0.40
Previous close
$0.42
Volume
76.0K
Market cap
$32.18M
Day range
$0.40 - $0.43
52 week range
$0.13 - $1.95
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 07, 2024 |
4 | Insider transactions | 1 | May 07, 2024 |
8-k | 8K-related | 13 | May 03, 2024 |
4 | Insider transactions | 1 | Apr 25, 2024 |
3 | Insider transactions | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 19, 2024 |
8-k | 8K-related | 14 | Apr 17, 2024 |
8-k | 8K-related | 14 | Apr 11, 2024 |
8-k | 8K-related | 14 | Apr 09, 2024 |
8-k | 8K-related | 14 | Apr 02, 2024 |